Is a dose reduction of pulsed steroids feasible for treatment of cardiac allograft rejection beyond 6 months?
Wahlers
T
T
Department of Cardiothoracic Surgery, Medical School, Hanover, FRG.
Heublein
B
B
Cremer
J
J
Fieguth
H G
HG
Albes
J
J
Kemnitz
J
J
Haverich
A
A
Borst
H G
HG
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous
D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone